[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Checkmab S.r.l.\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":38},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":4,"overallStatus":26,"whyStopped":4,"lastUpdateSubmitDate":27,"lastUpdatePostDateStruct":28,"startDateStruct":31,"completionDateStruct":33,"leadSponsor":35,"locationsCount":5},"100580830",false,"NCT06842407","Novel Targets for the Development of Monoclonal Antibodies for Immunotherapy)","Nuovi Bersagli Per lo Sviluppo di Anticorpi Monoclonali Per Immunoterapia - (Novel Targets for the Development of Monoclonal Antibodies for Immunotherapy)","Immuno-ab","Inclusion Criteria:\n\n* blood donors\n* age of 18 years or more\n* able to sign informed consent\n\nExclusion Criteria:\n\n* age below 18 years\n* Positive for HIV, HCV, HBV\n* not suitable for blood donation\n* not able to understand or sign informed consent",true,"ALL","18 Years",{"count":20,"type":21},600,"ESTIMATED","OBSERVATIONAL","The first objective of the project consists in the preclinical validation of new possible molecular targets associated with intratumoral T regulatory cells. The second objective consists in the selection of monoclonal antibodies with therapeutic potential, specific for the selected targets.",[25],"Healthy Donors","RECRUITING","2025-02-19",{"date":29,"type":30},"2025-02-24","ACTUAL",{"date":32,"type":30},"2023-04-01",{"date":34,"type":21},"2026-06-30",{"name":36,"class":37},"Checkmab S.r.l.","INDUSTRY",""]